These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2954693

  • 1. [The liquid phase C1q binding assay and its clinical application].
    Cheng PZ, Dong Y, Zhang NZ, Ji D, Dai X.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):69-71. PubMed ID: 2954693
    [No Abstract] [Full Text] [Related]

  • 2. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC, Bey RF, Loken KI.
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays.
    Yoshida H, Muso E, Inoue S, Furukawa F, Sekita K, Kawai C, Hamashima Y.
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433
    [No Abstract] [Full Text] [Related]

  • 4. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
    Woodroffe AJ, Nozza JM, Muller KD, McIntosh SL, Hale GM, Clarkson AR.
    J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
    [Abstract] [Full Text] [Related]

  • 5. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
    Kasukawa R.
    Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
    [No Abstract] [Full Text] [Related]

  • 6. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives].
    Corvetta A, Spaeth PJ, Panico F, Ghirelli PA, Orecchioni F, Danieli G.
    G Clin Med; 1983 Oct; 64(9-10):337-48. PubMed ID: 6198235
    [No Abstract] [Full Text] [Related]

  • 7. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
    Bratt T, Ohlson S.
    J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
    [Abstract] [Full Text] [Related]

  • 8. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME.
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [Abstract] [Full Text] [Related]

  • 9. [Detection of circulating immune complexes in patients with lupus erythematosus, viral hepatitis and rheumatoid arthritis using radioactive marked C1q].
    Nydegger U, Lambert PH, Miescher PA.
    Verh Dtsch Ges Inn Med; 1974 May; 80():1575-7. PubMed ID: 4217986
    [No Abstract] [Full Text] [Related]

  • 10. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
    Agnello V, Mitamura T.
    Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
    [Abstract] [Full Text] [Related]

  • 11. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
    Caillot G, Lamelin JP, Hartmann DJ, Ville G.
    Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
    [Abstract] [Full Text] [Related]

  • 12. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE, Moss IK, Mumford P, Horsfall A, Maini RN.
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [Abstract] [Full Text] [Related]

  • 13. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U, Heinz HP, Loos M.
    J Immunol Methods; 1987 Sep 24; 102(2):149-56. PubMed ID: 2443573
    [Abstract] [Full Text] [Related]

  • 14. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W, Hiepe F, Courault K, Porstmann B, Apostoloff E.
    Biomed Biochim Acta; 1983 Sep 24; 42(7-8):1027-35. PubMed ID: 6360166
    [Abstract] [Full Text] [Related]

  • 15. [Determination of immunocomplexes. III. A method using a solid surface for immunocomplex binding and use of C1q subcomponent of the first complement component (C1q SP)].
    Votruba T, Rákosník P.
    Cesk Epidemiol Mikrobiol Imunol; 1988 Feb 24; 37(1):15-22. PubMed ID: 2967114
    [No Abstract] [Full Text] [Related]

  • 16. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB, Sjöholm AG.
    Behring Inst Mitt; 1993 Dec 24; (93):292-8. PubMed ID: 8172579
    [Abstract] [Full Text] [Related]

  • 17. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K, Doi T, Muso E, Yoshida H, Kanatsu K, Hamashima Y.
    Clin Exp Immunol; 1984 Mar 24; 55(3):487-94. PubMed ID: 6608422
    [Abstract] [Full Text] [Related]

  • 18. [IgG-bound DNA and C1q-binding materials in iupus nephritis].
    Koyama A, Narita M, Lshida H, Inage H, Sano M, Tojo S.
    Nihon Jinzo Gakkai Shi; 1982 Mar 24; 24(3):267-74. PubMed ID: 6981719
    [No Abstract] [Full Text] [Related]

  • 19. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE, Schwartzman S, Diamond HS, Berkowitz E.
    Clin Exp Immunol; 1988 Apr 24; 72(1):37-42. PubMed ID: 3135129
    [Abstract] [Full Text] [Related]

  • 20. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG, Redecha PB, Kimberly RP, Christian CL.
    J Immunol; 1987 Feb 01; 138(3):739-45. PubMed ID: 3492531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.